Funds Stocks Activity Screener Pricing

Sign in Upgrade

Institutional ownership & 13F research, built on official SEC filings. Track what the smart money is buying and selling.

Research

Institutional Funds
Stocks & Ownership
Screener
Latest Activity

Product

Pricing
Sign In
Create Account
My Account

About

About FBInvestor
Data & Methodology
Disclaimer

© 2026 FBInvestor. Data sourced from SEC EDGAR Form 13F filings.

Not investment advice. For informational purposes only.

Revance Therapeutics Inc — Forecast · FBInvestor

Stocks / Revance Therapeutics Inc

Institutional Ownership

Revance Therapeutics Inc

CUSIP 761330109COMRVNCEURQ1 2025

Overview Short Owners Forecast Dividends Earnings Insider

Analyst forecast

Analyst recommendation trends (Buy / Hold / Sell consensus) come from a market-data feed. This activates once the forecast feed is connected and this ticker is covered.

Coming soon